Baxter International stock underperforms but shows value potential after Q1 results.

Baxter International's stock has struggled recently due to low growth, high debt, and challenges under new CEO Andrew Hider. Despite these issues, the company's valuation appears attractive both absolutely and relative to its future outlook. The Q1 results support a positive case for the stock, suggesting that with time and patience, investor sentiment could improve and the stock price may rise above $20.